Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Fireflies.ai | 2025 | Secondary Market | Undisclosed | San Francisco |
| Cynomi | 2025 | Series B | $37.0M | Herzliya |
| ThirtyFiveBio | 2025 | Series Unknown | Undisclosed | Abingdon |
| AttoTude | 2025 | Series B | $50.0M | Menlo Park |
| Page | 2025 | Seed | $2.9M | Toronto |
| Apex.AI | 2025 | Series B | Undisclosed | Palo Alto |
| Valid | 2025 | Seed | $5.5M | San Francisco |
| Neofin | 2025 | Seed | $6.0M | São Paulo |
| Aer Therapeutics | 2025 | Series Unknown | $5.0M | Raleigh |
| Reibus | 2025 | Series B | Undisclosed | Atlanta |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Fireflies.ai | Secondary Market | Undisclosed | San Francisco, United States |
| 127 | Cynomi | Series B | $37.0M | Herzliya, Israel |
| 128 | ThirtyFiveBio | Series Unknown | Undisclosed | Abingdon, United Kingdom |
| 129 | AttoTude | Series B | $50.0M | Menlo Park, United States |
| 130 | Page | Seed | $2.9M | Toronto, Canada |
| 131 | Apex.AI | Series B | Undisclosed | Palo Alto, United States |
| 132 | Valid | Seed | $5.5M | San Francisco, United States |
| 133 | Neofin | Seed | $6.0M | São Paulo, Brazil |
| 134 | Aer Therapeutics | Series Unknown | $5.0M | Raleigh, United States |
| 135 | Reibus | Series B | Undisclosed | Atlanta, United States |
Fireflies.ai is an AI‑powered meeting assistant that records, transcribes, summarizes, and analyzes meetings and conversations.
Cynomi provides an AI platform for automating risk assessments and compliance.
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
AttoTude is a THz interconnect technology company using THz radios to enhance bandwidth for AI and hyperscale data centers.
Page is an AI-powered external relations platform that provides real-time insights to help enterprises navigate government policies, media.
Apex.AI specializes in software systems for robotic and autonomous vehicles.
Neofin is a SaaS company that offers an AI-powered software for B2B payments workflows.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Reibus is a B2B marketplace for buying and selling metals that connects businesses and simplifies metal transactions.
Onkos Surgical is a surgical oncology company that develops implants and instruments for musculoskeletal tumor patients.
Enterpret analyzes customer feedback using AI and NLP, offering tailored insights for product growth.
Nivoda is a digital marketplace and supply chain for natural and lab-grown diamonds.
Treehouse is a software-enabled service for home electrification.
Glooko as a digital health company that offers a diabetes management platform to help users monitor and control their blood glucose levels.
Cashmere AI is a platform that helps wealth firms find and contact prospects using AI-based financial event data.
Halda Therapeutics is a research-stage drug discovery company.
Cayena offers a B2B marketplace for restaurants to procure inventory from suppliers with next day delivery and better payment terms.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Aim Security is a GenAI security platform that aids enterprises in securing their transformation and increasing business productivity.
Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Binarly is the most advanced automated AI/ML supply chain security platform to identify vulnerabilities in firmware and software components
Canaan Partners has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Canaan Partners's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics, Medical. The firm invests across 55 different industry categories.
Among tracked funding rounds, IDEAYA Biosciences received $263.0M in a Post Ipo Equity round. Canaan Partners's total known invested capital is $3.1B.
Canaan Partners's average investment size is $26.7M across its portfolio of 229 companies.
Recent Canaan Partners portfolio additions include Fireflies.ai, Cynomi, ThirtyFiveBio, AttoTude, Page. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors